100
Participants
Start Date
July 15, 2025
Primary Completion Date
April 30, 2027
Study Completion Date
October 31, 2027
Dexmedetomidine
"Intravenous bolus: between 0.2 and 0.5 mcg/kg.~followed by~Intravenous infusion: ranging from 0.2 to 0.7 mcg/kg/h to the discretion of the attending anesthesiologist.~Bolus will be initiated prior to surgical incision and infusion will be stopped at wound closure."
lidocaine
"Intravenous bolus: between 0.5 and 1.5 mg/kg.~followed by~Intravenous infusion: ranging from 0.5 to 2.0 mg/kg/h to the discretion of the attending anesthesiologist.~Bolus will be initiated prior to surgical incision and infusion will be stopped at wound closure."
control group
Usual care where systemic dexmedetomidine is not allowed and systemic lidocaine is permitted only for the prevention or treatment of propofol injection pain.
RECRUITING
CHU de Québec-Université Laval (Hôpital de l'Enfant-Jésus), Québec
Canadian Perioperative Anesthesia Clinical Trials (PACT) Group
UNKNOWN
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
International Anesthesia Research Society (IARS)
OTHER
CHU de Quebec-Universite Laval
OTHER